In the current study, we also demonstrated that RBPMS2 DNA methylation was related to the depth of tumor invasion, Borrmann classification and TNM stage, suggesting that DNA methylation of RBPMS2 was a promising molecular diagnostic biomarker of GC. Here, RBPMS2 is linked to gastric cancer.